6/12/2017 | CLHY | Market Commentary: Fortress, Six Flags, Cinemark, Help/Systems break; TransDigm dips on call to investigate
|
6/8/2017 | CLHY | Market Commentary: EagleClaw, Unitymedia, Masergy, TKC, Endurance, Grocery Outlet, American Airlines break
|
2/19/2015 | PP | Idera greenshoe exercised in $86.25 million public offering of stock
|
2/13/2015 | PP | Idera Pharmaceuticals prices $75 million public sale of stock at $3.75
|
2/9/2015 | PP | Idera Pharmaceuticals plans $75 million public offering shares
|
2/10/2014 | PP | Idera greenshoe exercised for $31.47 million public offering of units
|
2/5/2014 | PP | Idera Pharmaceuticals sells $27.37 million public units sale at $4.00
|
2/4/2014 | PP | Idera Pharmaceuticals aims to price public offering of stock, warrants
|
9/25/2013 | PP | Idera prices $21.28 million public sale of stock, warrants at $1.55
|
9/24/2013 | PP | Idera Pharmaceuticals reports plans to conduct public sale of shares
|
5/7/2013 | PP | Idera completes $16.5 million public offering of stock and warrants
|
5/2/2013 | PP | Idera Pharmaceuticals prices $8.75 million public units sale at $0.50
|
3/11/2013 | PP | Idera Pharmaceuticals to sell shares, warrants through public offering
|
11/13/2012 | PP | Idera Pharmaceuticals wraps $7 million private placement of preferreds
|
4/13/2012 | PP | Idera Pharmaceuticals arranges $10 million at market sales agreement
|
11/4/2011 | PP | Idera wraps $9.5 million private placement of convertible preferreds
|
8/3/2010 | PP | New Issue: Idera gives details of $15.1 million direct offering of equity units
|
8/2/2010 | PP | New Issue: Idera Pharmaceuticals publicizes $15 million direct offering of units
|
11/1/2007 | SS | Idera Pharmaceuticals stockholders sell shares, keeps 16.6% stake in company
|
2/15/2007 | PP | Idera Pharmaceuticals to automatically convert 4% notes due 2008
|
11/14/2006 | BT | Idera Pharmaceuticals' net loss up for the quarter, revenues steady
|
9/13/2006 | BT | Idera issued patent for compounds that target Toll-like receptor 9
|
7/25/2006 | BT | Idera forms oncology clinical advisory board
|
7/17/2006 | BT | Idera granted European, Australian patents on immune modulatory compounds
|
7/14/2006 | BTPP | Idera increases amount it may draw from $9.75 million equity line before registration statement is effective
|
6/29/2006 | BT | Idera's one-for-eight reverse stock split effective June 29
|
6/22/2006 | BT | Idera board, stockholders vote in favor of one-for-eight stock split
|
6/5/2006 | BT | Idera reports TLR9 agonists help chemotherapy treatments in animals
|
5/15/2006 | BT | Idera expands portfolio of Toll-Like Receptors, presents data at AAI meeting
|
3/27/2006 | BTPP | New Issue: Idera Pharmaceuticals closes $9.75 million placement of stock
|
3/27/2006 | PP | Market Commentary: Keryx Biopharmaceuticals stock rises on $82.8 million direct deal; Metabasis to raise $39.96 million
|
10/26/2005 | BT | Idera begins phase 1/2 oncology trial of HYB2055
|
10/20/2005 | BT | Idera asks to amend renal carcinoma phase II trial in response to high enrollment
|